Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands		Total	Redeemable Noncontrolling Interests	Total Stockholders’ Equity (Deficit)	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interests
Stockholders' equity, beginning of period at Jan. 03, 2016		$ 1,508,639	$ 69,104	$ 1,449,149	$ 137	$ 2,359,917	$ (155,265)	$ (8,023)	$ (747,617)	$ 59,490
Shares issued, beginning of period at Jan. 03, 2016					136,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(445,599)	(75,817)	(448,635)					(448,635)	3,036
Cumulative-effect upon adoption of ASC 606		500,820		500,820					500,820
Other comprehensive loss		785		785				785
Issuance of restricted stock to employees, net of cancellations		3		3	$ 3
Issuance of restricted stock to employees, net of cancellations (in shares)					2,836
Stock-based compensation expense		56,110		56,110		56,110
Tax benefit from convertible debt interest deduction		(2,822)		(2,822)		(2,822)
Tax benefit from stock-based compensation		(2,810)		(2,810)		(2,810)
Contributions from noncontrolling interests		(29,215)	(117,120)							(29,215)
Distributions to noncontrolling interests		(12,253)	(6,786)							(12,253)
Purchases of treasury stock		(21,519)		(21,519)	$ (1)		(21,518)
Purchases of treasury stock (in shares)					(1,039)
Stockholders' equity, end of period at Jan. 01, 2017		1,610,569	103,621	1,531,081	$ 139	2,410,395	(176,783)	(7,238)	(695,432)	79,488
Shares issued, end of period at Jan. 01, 2017					138,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(1,017,942)	(152,926)	(929,121)					(929,121)	(88,821)
Cumulative-effect upon adoption of ASC 606		(45,344)		(45,344)					(45,344)
Other comprehensive loss		4,230		4,230				4,230
Issuance of restricted stock to employees, net of cancellations		2		2	$ 2	0
Issuance of restricted stock to employees, net of cancellations (in shares)					1,739
Stock-based compensation expense		32,118		32,118		32,118
Contributions from noncontrolling interests		(125,500)	(71,928)							(125,500)
Distributions to noncontrolling interests		(11,988)	(7,387)							(11,988)
Purchases of treasury stock		(4,757)		(4,757)	$ (1)		(4,756)
Purchases of treasury stock (in shares)					(589)
Stockholders' equity, end of period at Dec. 31, 2017		692,388	15,236	588,209	$ 140	2,442,513	(181,539)	(3,008)	(1,669,897)	104,179
Shares issued, end of period at Dec. 31, 2017					139,658
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(888,326)	(29,171)	(811,091)					(811,091)	(77,235)
Other comprehensive loss		(1,142)		(1,142)				(1,142)
Issuance of restricted stock to employees, net of cancellations		2		2	$ 2
Issuance of restricted stock to employees, net of cancellations (in shares)					2,267
Stock-based compensation expense		25,790		25,790		25,790
Contributions from noncontrolling interests		(114,470)	(36,734)							(114,470)
Distributions to noncontrolling interests		(13,438)	(7,425)							(13,438)
Purchases of treasury stock		(5,531)		(5,531)	$ (1)		(5,530)
Purchases of treasury stock (in shares)					(747)
Reduction of non-controlling interest due to sale of interest in residential lease portfolio1	[1]	(61,766)	(15,374)							(61,766)
Noncontrolling interest buyout		(12,333)		(4,933)		(4,933)				(7,400)
Stockholders' equity, end of period at Dec. 30, 2018		$ (149,886)	$ 0	$ (208,696)	$ 141	$ 2,463,370	$ (187,069)	$ (4,150)	$ (2,480,988)	$ 58,810
Shares issued, end of period at Dec. 30, 2018					141,178

[1] See Note 4 "Business Combination and Divestitures".